# Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus

> **NCT00814294** · PHASE2,PHASE3 · COMPLETED · sponsor: **Diasome Pharmaceuticals** · enrollment: 239 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** placebo
- **DRUG:** Oral Hepatic Directed Vesicles (HDV)-Insulin (U-15)
- **DRUG:** Oral Hepatic Directed Vesicles (HDV)-Insulin (U-5)

## Key facts

- **NCT ID:** NCT00814294
- **Lead sponsor:** Diasome Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814294, "Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00814294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*